Showing results (781-790 of 5,007) with videos related to
Sort By:
Pageof 501
American Journal of Clinical Oncology|May 31, 2012
Bevacizumab and erlotinib in previously untreated inoperable and metastatic hepatocellular carcinomaRangaswamy Govindarajan, Eric Siegel, Issam Makhoul, et al.American Journal of Clinical Oncology|May 31, 2012
Chemotherapeutic strategies in advanced or metastatic pancreatic adenocarcinomaSyed F Zafar, Bassel F El-RayesAmerican Journal of Clinical Oncology|June 1, 1997
Fractionated stereotactic radiotherapy with cis-platinum radiosensitization in the treatment of recurrent, progressive, or persistent malignant astrocytomaJ Glass, C L Silverman, R Axelrod, et al.American Journal of Clinical Oncology|June 1, 1997
A phase II trial of edatrexate in patients with advanced renal cell carcinoma. An Eastern Cooperative Oncology Group studyR Dreicer, K J Propert, T Kuzel, et al.American Journal of Clinical Oncology|June 1, 1997
Cisplatin, mitomycin, and vindesine followed by intraoperative and postoperative radiotherapy for stage III non-small cell lung cancer: final results of a phase II studyJ Aristu, J Rebollo, R Martínez-Monge, et al.American Journal of Clinical Oncology|June 1, 1997
Pretreatment characteristics of carcinoid tumors of the lung which predict aggressive behaviorP Perkins, B L Kemp, J B Putnam, et al.American Journal of Clinical Oncology|June 1, 1997
A prospective phase II trial to evaluate the efficacy and toxicity of hepatic arterial infusion of ifosfamide in patients with inoperable localized hepatocellular carcinomaI A Malik, W A Khan, S Haq, et al.American Journal of Clinical Oncology|June 1, 1997
Megestrol acetate in the treatment of hormone refractory prostate cancerJ L Osborn, D C Smith, D L TrumpAmerican Journal of Clinical Oncology|August 26, 2016
Does Specialty Bias Trump Evidence in the Management of High-risk Prostate Cancer?Amar U Kishan, Gillian Duchesne, Pin-Chieh Wang, et al.American Journal of Clinical Oncology|February 24, 2010
Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapyShane Lloyd, James B Yu, Lynn D Wilson, et al.Pageof 501